Noridian held a conference call to discuss its plans to expand coverage for non-invasive ffr-CT and to ban coverage for invasive FFR if a non-invasive test has been done. This will affect the Medicare plans in the 12 states that Noridian administers. SCAI-raised initial concerns on a May 20, 2020 conference call and we'll be filing written comments by  June 21, 2020.

Noridian’s proposed policy may be seen here.